Fujian Aonong Biological Technology Group Incorporation Limited reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 13,322.02 million compared to CNY 7,334.95 million a year ago. Revenue was CNY 13,322.02 million compared to CNY 7,334.95 million a year ago. Net loss was CNY 502.87 million compared to net income of CNY 502.27 million a year ago. Basic loss per share from continuing operations was CNY 0.78 compared to basic earnings per share from continuing operations of CNY 0.85 a year ago.